← Leaderboards
Richard Rothman
Johns Hopkins University
$29,371,651
Attributed
$29,371,651
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.4M · FY2005–21$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$29,371,651 · 3
By mechanism
N01$29,218,640 · 1
M01$153,011 · 2
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Xiao-Fang Yu$15,220,244
- Donald S. Burke$42,062,956
- Sabra L Klein$13,115,675
- Carl A Latkin$38,006,118
- David D. Celentano$57,488,358
Others in their field
Top investigators on “Medical”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$422,116,177
- Richard K. Wilson · Washington University$281,315,172
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$275,147,130
Research focus
MedicalPathway InteractionsPandemic DiseaseVirusPublic Health PracticeInstitutionBasic ScienceLinkInfluenzaInfluenza OutbreakPandemic InfluenzaSeasonal InfluenzaPublic HealthGovernmentInfluenza SurveillanceInfluenza A VirusUniversal Influenza VaccineMedical ComplicationAvian InfluenzaBacterial EndocarditisClinical ResearchDiagnosis Design /EvaluationDisease /Disorder Proneness /RiskElectrocardiography
Grant awards (25)
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$131,053
N01 · FY2021 · AI · contact PI
CEIRS - SARS-CoV-2 RESEARCH$2,582,715
N01 · FY2020 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$2,031,818
N01 · FY2020 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS$507,955
N01 · FY2020 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS$2,443,352
N01 · FY2019 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$1,796,843
N01 · FY2019 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$730,716
N01 · FY2019 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$449,212
N01 · FY2019 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$1,459,624
N01 · FY2018 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$1,382,616
N01 · FY2018 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS$867,817
N01 · FY2018 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$589,536
N01 · FY2018 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$486,541
N01 · FY2018 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$243,271
N01 · FY2018 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$243,271
N01 · FY2018 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$2,787,937
N01 · FY2017 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$601,278
N01 · FY2017 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$3,339,975
N01 · FY2016 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$3,583,595
N01 · FY2015 · AI · contact PI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)$2,959,515
N01 · FY2014 · AI · contact PI
AN ALTERNATIVE APPROACH FOR EVALUATION OF THE FEBRILE INTRAVENOUS DRUG USER$33,146
M01 · FY2005 · RR
An Alternative Approach for Evaluation of the Febrile Intravenous Drug User...$119,865
M01 · FY2004 · RR
EVALUATION OF FEBRILE IV DRUG USERS--GUIDELINES FOR EMERGENCY MANAGEMENT$0
M01 · FY2002 · RR
EVALUATION OF FEBRILE IV DRUG USERS--GUIDELINES FOR EMERGENCY MANAGEMENT$0
M01 · FY2001 · RR
EVALUATION OF FEBRILE IV DRUG USERS--GUIDELINES FOR EMERGENCY MANAGEMENT$0
M01 · FY2000 · RR